Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum YM BioSciences Inc YMI

Bullboard (NYSEAM:YMI)

View:
Post by bihiceloon Mar 28, 2011 2:59pm

on the move

    New 52 week high
Post by daydream1on Dec 20, 2010 11:12am

Back to where it should be

I am glad to see that upon the latest financing the investors sentiment agree with a ~$2.00 valuation of the share price. GoodluckD.
Post by salesguymmon Dec 15, 2010 10:02am

little guys

All we can do now is sit back and watch..and hope for more good news. On the positive side, there must be a lot of interest in the company and it's potential with their ability to raise as much $$ ...more  
Comment by daydream1on Dec 15, 2010 8:40am

RE: Is that all it's worth????

Due to there additional trial I was anticipating YM to be in need of more cash, but as you mentioned I too am disappointed at the $1.60 offer.  For one I was hoping that YM would take in a ...more  
Post by salesguymmon Dec 14, 2010 11:42am

Is that all it's worth????

Been a long time holder of YM and am very disappointed that management would take shareholders back to this level. Things were looking very positive with solid positive news and  the share price ...more  
Comment by redcoatson Dec 06, 2010 10:49pm

RE: Phase I/II Trial of JAK1/JaK2 Inhibitor CYT387

Yes! We've been waiting a long time for a leading product. Perhaps this is it.
Post by daydream1on Dec 06, 2010 2:02pm

Phase I/II Trial of JAK1/JaK2 Inhibitor CYT387

Great results.  Now if only YM could secure a deal with one of the major pharmaceutical Co. on distribution, YM would be off to the races.GoodluckD.
Comment by RegenTechon Nov 28, 2010 11:42pm

RE: december

I do not have a crystal ball nor do any others here.My guess is that we see it move to the next level as in 2.75 to 3.50 range during the first quarter of 2011.  If the data from Nimo trials that ...more  
Post by taleb186on Nov 28, 2010 10:25pm

december

does anyone have an outlook where this will go after that presentation in early december?
Comment by taleb186on Nov 28, 2010 10:24pm

RE: RE: potential

well I dont know anything about this company yet. Ive just been looking at the charts and market orders. that 1.82 close occurred on specifically one trade performed 20 minutes before the close on 250 ...more  
Comment by redcoatson Nov 26, 2010 11:43pm

RE: potential

Anybody know why the big drop today? Seems a little strange given the news has been all good.
Post by taleb186on Nov 21, 2010 10:49pm

potential

Guys, New to this board. Going to do some reading. But couple questions. Is YM's cyt387 better than incytes? And whats the potential here in YM, just based on opinions. I seen this stock last year ...more  
Post by ftt998on Nov 11, 2010 3:26pm

BT: Dundee upgrades YM

https://biotuesday.ca/2010/11/11/dundee-upgrades-ym-to-buy-venture-risk/
Post by redcoatson Oct 13, 2010 9:27pm

Does YM

stand for YoYo Mon? Back up again tomorrow?
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities